Details of the Drug

General Information of Drug (ID: DMWOJ5N)

• Drug Name: 2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide
• Synonyms: CHEMBL174051; 2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide; BDBM50015169

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 241.28
  Logarithm of the Partition Coefficient (xlogp); 2.5
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 2
• Chemical Identifiers:
  Formula: C15H15NO2
  IUPAC Name: N-hydroxy-N-methyl-2-(4-phenylphenyl)acetamide
  Canonical SMILES: CN(C(=O)CC1=CC=C(C=C1)C2=CC=CC=C2)O
  InChI: InChI=1S/C15H15NO2/c1-16(18)15(17)11-12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-10,18H,11H2,1H3
  InChIKey: OKCNSKAFTYDWAP-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 13670400
  TTD ID: D02HQK

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Arachidonate 5-lipoxygenase (5-LOX)	TT2J34L	LOX5_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Arachidonate 5-lipoxygenase (5-LOX)	DTT	ALOX5	4.15E-01	-0.06	-0.15

References

• [1] Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8.